UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance

Clinical pharmacology and therapeutics, 2018-11, Vol.104 (5), p.890-899

2018

Volltextzugriff (PDF)

Renal Transporters in Drug Development

Annual review of pharmacology and toxicology, 2013-01, Vol.53 (1), p.503-529

2013

Volltextzugriff (PDF)

Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metformin

Molecular pharmacology, 2015-07, Vol.88 (1), p.75-83

2015

Volltextzugriff (PDF)

A framework for understanding sources of bias in medication adherence research

British journal of clinical pharmacology, 2023-11, Vol.89 (11), p.3444-3453

2023

Volltextzugriff (PDF)

Voriconazole: an audit of hospital-based dosing and monitoring and evaluation of the predictive performance of a dose-prediction software package

Journal of antimicrobial chemotherapy, 2020-07, Vol.75 (7), p.1981-1984

2020

Volltextzugriff (PDF)

The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin

Clinical pharmacokinetics, 2016-06, Vol.55 (6), p.711-721

2016

Volltextzugriff (PDF)

The Effect of Nizatidine, a MATE2K Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Volunteers

Clinical pharmacokinetics, 2016-04, Vol.55 (4), p.495-506

2016

Volltextzugriff (PDF)

The impact of genetic variability in urate transporters on oxypurinol pharmacokinetics

Clinical and translational science, 2023-03, Vol.16 (3), p.422-428

2023

Volltextzugriff (PDF)

Therapeutic Drug Monitoring and Biomarkers; towards Better Dosing of Antimicrobial Therapy

Pharmaceutics, 2024-05, Vol.16 (5), p.677

2024

Volltextzugriff (PDF)

Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol

Clinical pharmacokinetics, 2007-01, Vol.46 (8), p.623-644

2007

Volltextzugriff (PDF)

Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis

Journal of clinical medicine, 2019-01, Vol.8 (1), p.45

2019

Volltextzugriff (PDF)

Gene Expression Profiling of Transporters in the Solute Carrier and ATP-Binding Cassette Superfamilies in Human Eye Substructures

Molecular pharmaceutics, 2013-02, Vol.10 (2), p.650-663

2013

Volltextzugriff (PDF)

Patient‐Led Urate Self‐Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility Study

ACR open rheumatology, 2024-07, Vol.6 (7), p.403-411

2024

Volltextzugriff (PDF)

Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans

Frontiers in pharmacology, 2016-06, Vol.7, p.135-135

2016

Volltextzugriff (PDF)

Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review

Clinical pharmacokinetics, 2020-11, Vol.59 (11), p.1357-1392

2020

Volltextzugriff (PDF)

Pharmacokinetics of Metformin in Patients Receiving Regular Hemodiafiltration

American journal of kidney diseases, 2016-12, Vol.68 (6), p.990-992

2016

Volltextzugriff (PDF)

Clinical Pharmacokinetics in Kidney Disease: Fundamental Principles

Clinical journal of the American Society of Nephrology, 2018-07, Vol.13 (7), p.1085-1095

2018

Volltextzugriff (PDF)

Comment on “Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies” and “High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints”

Clinical pharmacokinetics, 2024-05, Vol.63 (5), p.731-733

2024

Volltextzugriff (PDF)

Predicting early bactericidal activity using pre-clinical data for tuberculosis drugs: a platform for model-informed drug discovery and development

The European respiratory journal, 2023-08, Vol.62 (2), p.2301108

2023

Volltextzugriff (PDF)

Clinical Pharmacokinetics in Kidney Disease: Application to Rational Design of Dosing Regimens

Clinical journal of the American Society of Nephrology, 2018-08, Vol.13 (8), p.1254-1263

2018

Volltextzugriff (PDF)

Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease

Drug safety, 2020-12, Vol.43 (12), p.1211-1221

2020

Volltextzugriff (PDF)

A Model Averaging/Selection Approach Improves the Predictive Performance of Model‐Informed Precision Dosing: Vancomycin as a Case Study

Clinical pharmacology and therapeutics, 2021-01, Vol.109 (1), p.175-183

2021

Volltextzugriff (PDF)

Using seconds‐resolved pharmacokinetic datasets to assess pharmacokinetic models encompassing time‐varying physiology

British journal of clinical pharmacology, 2023-09, Vol.89 (9), p.2798-2812

2023

Volltextzugriff (PDF)

Barriers and opportunities for the clinical implementation of therapeutic drug monitoring in oncology

British journal of clinical pharmacology, 2021-02, Vol.87 (2), p.227-236

2021

Volltextzugriff (PDF)

Evaluation of Published Population Pharmacokinetic Models to Inform Tacrolimus Therapy in Adult Lung Transplant Recipients

Therapeutic drug monitoring, 2024-08, Vol.46 (4), p.434-445

2024

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(92)
Buchkapitel
(1)

Sprache

Englisch
(93)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance

Renal Transporters in Drug Development

Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metformin

A framework for understanding sources of bias in medication adherence research

Voriconazole: an audit of hospital-based dosing and monitoring and evaluation of the predictive performance of a dose-prediction software package

The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin

The Effect of Nizatidine, a MATE2K Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Volunteers

The impact of genetic variability in urate transporters on oxypurinol pharmacokinetics

Therapeutic Drug Monitoring and Biomarkers; towards Better Dosing of Antimicrobial Therapy

Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol

Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis

Gene Expression Profiling of Transporters in the Solute Carrier and ATP-Binding Cassette Superfamilies in Human Eye Substructures

Patient‐Led Urate Self‐Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility Study

Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans

Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review

Pharmacokinetics of Metformin in Patients Receiving Regular Hemodiafiltration

Clinical Pharmacokinetics in Kidney Disease: Fundamental Principles

Predicting early bactericidal activity using pre-clinical data for tuberculosis drugs: a platform for model-informed drug discovery and development

Clinical Pharmacokinetics in Kidney Disease: Application to Rational Design of Dosing Regimens

Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease

A Model Averaging/Selection Approach Improves the Predictive Performance of Model‐Informed Precision Dosing: Vancomycin as a Case Study

Using seconds‐resolved pharmacokinetic datasets to assess pharmacokinetic models encompassing time‐varying physiology

Barriers and opportunities for the clinical implementation of therapeutic drug monitoring in oncology

Evaluation of Published Population Pharmacokinetic Models to Inform Tacrolimus Therapy in Adult Lung Transplant Recipients

Suchergebnisse filtern